Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,437 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Recruiting

Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors

NCT05533697

Conditions
Advanced Solid Tumors, Disease Attributes, Neoplasm Metastasis, +5 more
Locations
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • University of Colorado Cancer Center Aurora, Colorado, United States
  • George Washington University Washington D.C., District of Columbia, United States
View all 39 locations
View Trial Details
Recruiting

Digital Monitoring of Self-reported Symptoms by Patients Treated With Cabozantinib Plus Nivolumab for Advanced Clear-cell Renal Carcinoma

NCT07028125

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +20 more
Locations
  • Centre Hospitalier d'Annecy Annecy, France
  • Institut Sainte Catherine Avignon, France
  • Centre Hospitalier de Bayeux Bayeux, France
  • CH Boulogne sur Mer Boulogne-sur-Mer, France
View all 19 locations
View Trial Details
Recruiting

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

NCT07137416

Conditions
Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Diseases, +24 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

NCT07218380

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Clearview Cancer Institute Huntsville, Alabama, United States
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine Irvine, California, United States
View all 286 locations
View Trial Details
Recruiting

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

NCT06792695

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Research Site Scottsdale, Arizona, United States
  • Research Site Los Angeles, California, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Chicago, Illinois, United States
View all 76 locations
View Trial Details
Recruiting

A Study of Lorlatinib in Combination With Ramucirumab in People With Lung Cancer

NCT06007937

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +16 more
Locations
  • Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering West Harrison (All Protocol Activities) Harrison, New York, United States
View Trial Details
Recruiting

PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan

NCT05573893

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
Locations
  • Research Site Amberg, Germany
  • Research Site Ansbach, Germany
  • Research Site Apolda, Germany
  • Research Site Aschaffenburg, Germany
View all 108 locations
View Trial Details
Recruiting

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

NCT07647328

Conditions
Breast Diseases, Breast Neoplasms, ER-Positive HER2-Negative Breast Cancer, +8 more
Locations
  • Research Site Duarte, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site Marietta, Georgia, United States
  • Research Site Evanston, Illinois, United States
View all 84 locations
View Trial Details

Related conditions